EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IAP Antagonists Selectively Eliminate Therapy‐Induced Senescent Cancer Cells via TNFα ‐Independent Apoptosis

Hiroaki Ochiiwa, Takeshi Wakasa, Yuki Kataoka, Koji Ando iD, Eiji Oki iD, Yoshihiko Maehara, Makoto Iimori, Hiroyuki Kitao iD

Cancer Science · 2026-04 · 117 (4) · 1043-1056

DOI: 10.1111/cas.70329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 27.01.2026. Verfasst von Hiroaki Ochiiwa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Apoptosis, Tumor Necrosis Factor-alpha, Cellular Senescence, Inhibitor of Apoptosis Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Kobayashi Foundation for Cancer Research, Princess Takamatsu Cancer Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapy‐induced senescence (TIS) is a state in which cancer cells enter growth arrest following chemotherapy. TIS cancer cells influence the tumor microenvironment through their senescence‐associated secretory phenotype and independently acquire stem‐like properties, both of which contribute to increased aggressiveness and tumor relapse. Here, we show that AZD5582 and AT406, potent antagonists of cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1 and cIAP2) and X‐linked inhibitor of apoptosis protein (XIAP), selectively eliminated HCT116 and RKO cells that had undergone senescence following treatment with a chemotherapeutic agent such as trifluridine, camptothecin, or doxorubicin. This elimination occurred via apoptosis associated with caspase 8 activation. These TIS cancer cells produced and secreted tumor necrosis factor α (TNFα); however, the selective cytotoxicity of IAP antagonists toward TIS cells was unexpectedly largely TNFα‐independent. Consistently, the same IAP antagonists sensitized cancer cells treated with nutlin‐3a, which induces senescence without TNFα production. Depletion of both cIAP1 and XIAP recapitulated the selective cytotoxicity against both TIS and nutlin‐3a‐induced senescent cancer cells. At physiological concentrations, TNFα sensitized non‐senescent, proliferating cancer cells, but not TIS and nutlin‐3a‐induced senescent cancer cells, to apoptosis in the presence of IAP antagonists. Collectively, these findings suggest that IAP antagonists could serve as effective concomitant agents to TIS‐inducing chemotherapy that promotes TNFα secretion within tumors, functioning not only as TNFα‐independent senolytics but also as potentiators of TNFα‐mediated apoptosis in adjacent non‐senescent, proliferating cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisTumor Necrosis Factor-alphaCellular SenescenceInhibitor of Apoptosis ProteinsAntineoplastic AgentsNeoplasmsHumansX-Linked Inhibitor of Apoptosis ProteinCell Line, TumorImidazolesPiperazinesCaspase 8HCT116 Cells

Stichwörter der Autor:innen

IAP antagonistTNFαcaspase 8senolysistherapy‐induced senescence

Substanzen

Tumor Necrosis Factor-alphaInhibitor of Apoptosis ProteinsX-Linked Inhibitor of Apoptosis ProteinImidazolesAntineoplastic AgentsPiperazinesCaspase 8XIAP protein, humannutlin 3

Autor:innen und Institutionen

  • Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Taiho Pharmaceutical Co. Ltd., Tokyo, Japan.
  • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, Japan.
  • Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan.
  • Oral Medicine Research Center, Fukuoka Dental College, Fukuoka, Japan.

ORCID-Profile: Koji Ando, Eiji Oki, Hiroyuki Kitao

Förderung

  • Japan Society for the Promotion of Science
  • Kobayashi Foundation for Cancer Research
  • Princess Takamatsu Cancer Research Fund

Zitieren

APA

Ochiiwa, H., Wakasa, T., Kataoka, Y., Ando, K., Oki, E., Maehara, Y., Iimori, M., & Kitao, H. (2026). IAP Antagonists Selectively Eliminate Therapy‐Induced Senescent Cancer Cells via TNFα ‐Independent Apoptosis. Cancer Science, 117(4), 1043-1056. https://doi.org/10.1111/cas.70329

Vancouver

Ochiiwa H, Wakasa T, Kataoka Y, Ando K, Oki E, Maehara Y, et al. IAP Antagonists Selectively Eliminate Therapy‐Induced Senescent Cancer Cells via TNFα ‐Independent Apoptosis. Cancer Science. 2026;117(4):1043-1056. doi:10.1111/cas.70329

BibTeX
@article{Ochiiwa2026,
  author = {Ochiiwa, Hiroaki and Wakasa, Takeshi and Kataoka, Yuki and Ando, Koji and Oki, Eiji and Maehara, Yoshihiko and Iimori, Makoto and Kitao, Hiroyuki},
  title = {IAP Antagonists Selectively Eliminate Therapy‐Induced Senescent Cancer Cells via TNFα ‐Independent Apoptosis},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {4},
  pages = {1043--1056},
  doi = {10.1111/cas.70329}
}
Kostenlos starten →